BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 21076089)

  • 1. Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.
    Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Ozonoff A; Miller JP; Kalinyak JE
    Radiology; 2011 Jan; 258(1):59-72. PubMed ID: 21076089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer.
    Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Kalinyak JE
    AJR Am J Roentgenol; 2012 Jan; 198(1):219-32. PubMed ID: 22194501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging.
    Schilling K; Narayanan D; Kalinyak JE; The J; Velasquez MV; Kahn S; Saady M; Mahal R; Chrystal L
    Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):23-36. PubMed ID: 20871992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.
    Berg WA; Gutierrez L; NessAiver MS; Carter WB; Bhargavan M; Lewis RS; Ioffe OB
    Radiology; 2004 Dec; 233(3):830-49. PubMed ID: 15486214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer.
    Berg WA; Weinberg IN; Narayanan D; Lobrano ME; Ross E; Amodei L; Tafra L; Adler LP; Uddo J; Stein W; Levine EA;
    Breast J; 2006; 12(4):309-23. PubMed ID: 16848840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Cancer Detection Using a Low-Dose Positron Emission Digital Mammography System.
    Freitas V; Li X; Scaranelo A; Au F; Kulkarni S; Ghai S; Taeb S; Bubon O; Baldassi B; Komarov B; Parker S; Macsemchuk CA; Waterston M; Olsen KO; Reznik A
    Radiol Imaging Cancer; 2024 Mar; 6(2):e230020. PubMed ID: 38334470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy.
    Kim EJ; Kang BJ; Kim SH; Youn IK; Baek JE; Lee HS
    Radiology; 2017 Sep; 284(3):656-666. PubMed ID: 28419815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT.
    Kalinyak JE; Berg WA; Schilling K; Madsen KS; Narayanan D; Tartar M
    Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):260-75. PubMed ID: 24085500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Internal Mammary Lymph Nodes with Silicone Breast Implants at MR Imaging after Oncoplastic Surgery.
    Sutton EJ; Watson EJ; Gibbons G; Goldman DA; Moskowitz CS; Jochelson MS; Dershaw DD; Morris EA
    Radiology; 2015 Nov; 277(2):381-7. PubMed ID: 26098457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer.
    Tafra L; Cheng Z; Uddo J; Lobrano MB; Stein W; Berg WA; Levine E; Weinberg IN; Narayanan D; Ross E; Beylin D; Yarnall S; Keen R; Sawyer K; Van Geffen J; Freimanis RL; Staab E; Adler LP; Lovelace J; Shen P; Stewart J; Dolinsky S
    Am J Surg; 2005 Oct; 190(4):628-32. PubMed ID: 16164937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast MR imaging screening in women with a history of breast conservation therapy.
    Gweon HM; Cho N; Han W; Yi A; Moon HG; Noh DY; Moon WK
    Radiology; 2014 Aug; 272(2):366-73. PubMed ID: 24635678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretation of positron emission mammography and MRI by experienced breast imaging radiologists: performance and observer reproducibility.
    Narayanan D; Madsen KS; Kalinyak JE; Berg WA
    AJR Am J Roentgenol; 2011 Apr; 196(4):971-81. PubMed ID: 21427351
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Watanabe G; Itoh M; Duan X; Watabe H; Mori N; Tada H; Suzuki A; Miyashita M; Ohuchi N; Ishida T
    Eur Radiol; 2018 May; 28(5):1929-1937. PubMed ID: 29218614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts.
    Rhodes DJ; Hruska CB; Phillips SW; Whaley DH; O'Connor MK
    Radiology; 2011 Jan; 258(1):106-18. PubMed ID: 21045179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation of positron emission mammography: feature analysis and rates of malignancy.
    Narayanan D; Madsen KS; Kalinyak JE; Berg WA
    AJR Am J Roentgenol; 2011 Apr; 196(4):956-70. PubMed ID: 21427350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
    Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
    Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly Diagnosed Breast Cancer: Comparison of Contrast-enhanced Spectral Mammography and Breast MR Imaging in the Evaluation of Extent of Disease.
    Lee-Felker SA; Tekchandani L; Thomas M; Gupta E; Andrews-Tang D; Roth A; Sayre J; Rahbar G
    Radiology; 2017 Nov; 285(2):389-400. PubMed ID: 28654337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG.
    Murthy K; Aznar M; Thompson CJ; Loutfi A; Lisbona R; Gagnon JH
    J Nucl Med; 2000 Nov; 41(11):1851-8. PubMed ID: 11079494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abbreviated Breast Magnetic Resonance Imaging for Supplemental Screening of Women With Dense Breasts and Average Risk.
    Weinstein SP; Korhonen K; Cirelli C; Schnall MD; McDonald ES; Pantel AR; Zuckerman S; Borthakur A; Conant EF
    J Clin Oncol; 2020 Nov; 38(33):3874-3882. PubMed ID: 32931396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Whole-Body (18)F FDG PET/MR Imaging and Whole-Body (18)F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer.
    Melsaether AN; Raad RA; Pujara AC; Ponzo FD; Pysarenko KM; Jhaveri K; Babb JS; Sigmund EE; Kim SG; Moy LA
    Radiology; 2016 Oct; 281(1):193-202. PubMed ID: 27023002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.